Study to Identify if Chemist Confessions Retinol Cream Works to Improve the Appearance of Early Signs of Aging.

February 6, 2023 updated by: Chemist Confessions, Inc.
Chemist Confessions has developed a retinol cream with the aim to improve the appearance of early signs of aging, such as fine lines, dark spots, hyperpigmentation, and crow's feet. In this phase, Chemist Confessions plans to collect self-reported outcomes and photographic images to understand the assessment of the efficacy of treatment from the participant's perspective, and if participants see an improvement in their fine lines, wrinkles, dark spots, hyperpigmentation, and crow's feet.

Study Overview

Detailed Description

Based on a review of existing literature and previous studies, retinol has been found to have positive effects, however, due to study limitations, there are also conflicting results. Therefore, in this study, participants will receive Chemist Confessions retinol cream to understand if the Chemist Confessions cream has an impact on the participant's skin, and even potentially reduces fine lines, wrinkles, dark spots, hyperpigmentation, and crow's feet of the skin, and also to understand concepts considered essential by individuals taking retinol products.

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Santa Monica, California, United States, 90404
        • Citruslabs

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 50 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female between 30-50 years old
  • Must be in good general health
  • Must experience early-stage wrinkles that are not treated by topical or oral prescription drugs/medication
  • May experience hyperpigmentation, dark spots and dark circles
  • Must maintain the following skincare routine containing: cleansing, allowed moisturizer and study specific sunscreen
  • Must use study provided sunscreen daily
  • Must discontinue the use of other retinoids 4 weeks before the study start date
  • Must have some general knowledge of retinoid use
  • Must be willing to comply with the requirements of the protocol
  • Must be able to communicate in English
  • Must be able to tell left from right
  • Must willing to add the retinoid cream to their skincare routine
  • Must provide written informed consent form (ICF)
  • Is willing and able to share feedback and take skin pictures via the used technology portal
  • Must be willing to refrain from using products with chemical exfoliants glycolic acid and lactic acid during the duration of the study

Exclusion Criteria:

  • Unwilling to provide consent
  • Unwilling to add the retinoid cream to their normal skincare routine
  • Unwilling to follow the routine of the protocol
  • Uses moisturizers that include chemical exfoliating ingredients such as glycolic acid, lactic acid or salicylic acid
  • Use of other oral retinoids
  • Use of prescription medication relevant to the skin
  • Undergoing any cosmetic procedures during the study including Botox, laser or chemical peel treatments
  • Deep-set of wrinkles
  • Use of prescription drug (topical or oral) that is targeted at any sort of skin condition (for example retinoids)
  • Is pregnant or nursing, or attempting a pregnancy
  • Used retinoids before with an adverse reaction
  • Has a self-identified sensitive skin type
  • Has any learning and/or cognitive difficulties that prevent him/her reading and understanding questionnaires and surveys (e.g. dementia)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: SINGLE_GROUP
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Retinol face cream
Retinol face cream on one half of the participant's face
Retinol face cream
PLACEBO_COMPARATOR: Placebo face cream
Placebo face cream on one half of the participant's face
Placebo face cream

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improvement of skin appearance of early signs of aging
Time Frame: 12 weeks

The primary objective of this study is to understand if Chemist Confessions retinol cream is capable of improving the appearance of early signs of aging such as fine lines, dark spots, wrinkles, hyperpigmentation and crow's feet, and to determine if it helps to improve the overall skin health by promoting hydrated, brightened skin for study participants.

To evaluate the improvement of this outcome measure VISIA imaging will be used.

12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2022

Primary Completion (ACTUAL)

November 30, 2022

Study Completion (ACTUAL)

November 30, 2022

Study Registration Dates

First Submitted

September 1, 2021

First Submitted That Met QC Criteria

September 2, 2021

First Posted (ACTUAL)

September 9, 2021

Study Record Updates

Last Update Posted (ACTUAL)

February 8, 2023

Last Update Submitted That Met QC Criteria

February 6, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 20218Chemist

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Retinol face cream

Subscribe